SOUTH SAN FRANCISCO, Calif. (AP) 鈥� SOUTH SAN FRANCISCO, Calif. (AP) 鈥� CytomX Therapeutics Inc. (CTMX) on Thursday reported a loss of $18.2 million in its first quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 10 cents.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.
The biopharmaceutical company posted revenue of $10.3 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $3.5 million.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/CTMX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
